Review




Structured Review

Auditec Inc duration pattern test (dpt)
Duration Pattern Test (Dpt), supplied by Auditec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/duration+pattern+sequence+test++dps+/pmc11813184-139-29-18
Average 90 stars, based on 1 article reviews
duration pattern test (dpt) - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

other:

Article Title: DPOAE growth function in schoolchildren with impaired temporal ordering skills
Article Snippet: Subsequent to the compliance with the inclusion criteria, the participants performed the following temporal processing assessments (children's version, Auditec Saint Louis ( ) ): Frequency Pattern Test (FPT) and Duration Pattern Test (DPT).

Article Title: Temporal Ordering and Auditory Resolution in Individuals with Sensorineural Hearing Loss
Article Snippet: The tests were a frequency pattern test (FPT), a duration pattern test (DPT), and an RGDT (standard and expanded versions), all commercialized by Auditec, Inc. (Saint Louis, MO, US).

Article Title: Age-Related Listening Performance Changes Across Adulthood
Article Snippet: Design: We assessed 80 participants with normal hearing, at least 10 years of education, and normal global cognition.. The participants completed various auditory tests, including speech-in-noise, dichotic digits, duration, pitch pattern sequence, gap in noise, and masking level difference.. In addition, we conducted working memory assessments and administered a questionnaire on self-perceived hearing difficulties.

Article Title: Auditory Processing Disorder as the Sole Manifestation of a Cerebellopontine and Internal Auditory Canal Lesion.
Article Snippet: Background: Clinical importance of auditory processing disorder (APD) testing is often overlooked and regarded with skepticism given the challenging interpretation of results and the current growing debate of its nature and clinical entity.. Purpose: Presentation of this case is highly educational as APD is the single clinical manifestation of a large cerebellopontine and internal auditory canal lesion.. Research Design: A case report.

Sequencing:

Article Title: Impact of Lipid-Inflammatory-Oxidative Metabolism on Auditory Skills after Hearing Aid Fitting in the Elderly.
Article Snippet: This study aimed to assess whether lipid-inflammatory-oxidative metabolism influences auditory processing skills, and whether they function in changing auditory performance after hearing aid fitting in the elderly.. Twelve subjects with bilateral hearing loss were submitted to blood tests (to check their lipid-inflammatory-oxidative metabolism) and auditory processing skill tests.. After 3 months of using the hearing aids, their auditory skills were re-evaluated and the data were correlated statistically.

Article Title: Comparison of two tests of auditory temporal resolution in children with central auditory processing disorder, adults with psychosis, and adult professional musicians.
Article Snippet: by the pure-tone audiogram, including processing of auditory elements essential to speech segregation.. Auditory processing is linked to language and speech skills.. Temporal processing is a component of auditory processing describing processing of time-related changes of auditory information.



Similar Products

86
Karius Inc karius test sequencing
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Karius Test Sequencing, supplied by Karius Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/karius+spectrum/pmc12968814-148-15-15
Average 86 stars, based on 1 article reviews
karius test sequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Karius Inc metagenomic sequencing based test
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Metagenomic Sequencing Based Test, supplied by Karius Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/generation+next+sequencing/pmc12955461-11-71-74
Average 86 stars, based on 1 article reviews
metagenomic sequencing based test - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

97
Foundation Medicine Inc next generation sequencing tests
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Next Generation Sequencing Tests, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/FoundationOne+Liquid+CDx/pm41686740-588-10-8
Average 97 stars, based on 1 article reviews
next generation sequencing tests - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
Psychology Software Tools test sequence
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Test Sequence, supplied by Psychology Software Tools, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/E-Prime/pmc12928708-80-12-19
Average 99 stars, based on 1 article reviews
test sequence - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Minitab Inc test sequence
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Test Sequence, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/sequence+test/10__1016_slash_j__wds__2026__100274-128-18-22
Average 86 stars, based on 1 article reviews
test sequence - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Quest Diagnostics notch3 cadasil sequencing test
Summary of enrolled plasma <t>mcfDNA-sequencing</t> studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.
Notch3 Cadasil Sequencing Test, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/cadasil+notch3+sequencing+test/us12496296-503-12-10
Average 86 stars, based on 1 article reviews
notch3 cadasil sequencing test - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Karius Inc bal fluid mcfdna sequencing test report
Flow diagram depicting patient and sample selection for the comparison of <t>BAL</t> fluid <t>mcfDNA</t> <t>sequencing</t> with the Karius® test and standard of care testing.
Bal Fluid Mcfdna Sequencing Test Report, supplied by Karius Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/mcfdna+sequencing/med_rxiv__2025__11__05__25339543-51-4-28
Average 86 stars, based on 1 article reviews
bal fluid mcfdna sequencing test report - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Invitae Inc next generation sequencing ngs diagnostic test
Flow diagram depicting patient and sample selection for the comparison of <t>BAL</t> fluid <t>mcfDNA</t> <t>sequencing</t> with the Karius® test and standard of care testing.
Next Generation Sequencing Ngs Diagnostic Test, supplied by Invitae Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/generation+next+sequencing/pmc12659938-53-10-15
Average 86 stars, based on 1 article reviews
next generation sequencing ngs diagnostic test - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Summary of enrolled plasma mcfDNA-sequencing studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.

Journal: Infection and Drug Resistance

Article Title: Refining the Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing in High-Risk Population of Infection: A Narrative Review

doi: 10.2147/IDR.S562107

Figure Lengend Snippet: Summary of enrolled plasma mcfDNA-sequencing studies published from 1st January 2015 to 28th February 2025. USA*: Refer to. , , , , China*: Refer to. , Germany*:Refer to.

Article Snippet: Christians et al developed a workflow that enriches ultrashort and rare mcfDNA fragments prior to Karius test sequencing, enabling the identification of key AMR genes, such as SCCmec, mecA, mecC, vanA, vanB, blaCTX-M , and blaKPC , with diagnostic yields ranging from 56.8% to 83.3%.

Techniques: Clinical Proteomics, Sequencing

The refinement strategy of clinical utility of plasma mcfDNA sequencing and prospective. *Co-mNGS Integration (Plasma + Blood Cell DNA): Cost-effectiveness should be further investigated, particularly in resource-limited settings.

Journal: Infection and Drug Resistance

Article Title: Refining the Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing in High-Risk Population of Infection: A Narrative Review

doi: 10.2147/IDR.S562107

Figure Lengend Snippet: The refinement strategy of clinical utility of plasma mcfDNA sequencing and prospective. *Co-mNGS Integration (Plasma + Blood Cell DNA): Cost-effectiveness should be further investigated, particularly in resource-limited settings.

Article Snippet: Christians et al developed a workflow that enriches ultrashort and rare mcfDNA fragments prior to Karius test sequencing, enabling the identification of key AMR genes, such as SCCmec, mecA, mecC, vanA, vanB, blaCTX-M , and blaKPC , with diagnostic yields ranging from 56.8% to 83.3%.

Techniques: Clinical Proteomics, Sequencing

Flow diagram depicting patient and sample selection for the comparison of BAL fluid mcfDNA sequencing with the Karius® test and standard of care testing.

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Flow diagram depicting patient and sample selection for the comparison of BAL fluid mcfDNA sequencing with the Karius® test and standard of care testing.

Article Snippet: For each sample, the BAL fluid mcfDNA sequencing test report included the name of each identified organism, the number of microbial reads found for the organism, and the Karius® designation for the pathogenicity of the organism (see Definitions).

Techniques: Selection, Comparison, Sequencing

Additive diagnostic value of BAL fluid mcfDNA sequencing with the Karius® test (KT-BAL) compared to standard of care (SOC) testing in immunocompromised patients with pneumonia. A) Number of organisms across all samples identified by either SOC alone, KT-BAL alone, or both techniques, split by KT-BAL category. B) Organisms identified exclusively by KT-BAL across all samples, split by KT-BAL category.

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Additive diagnostic value of BAL fluid mcfDNA sequencing with the Karius® test (KT-BAL) compared to standard of care (SOC) testing in immunocompromised patients with pneumonia. A) Number of organisms across all samples identified by either SOC alone, KT-BAL alone, or both techniques, split by KT-BAL category. B) Organisms identified exclusively by KT-BAL across all samples, split by KT-BAL category.

Article Snippet: For each sample, the BAL fluid mcfDNA sequencing test report included the name of each identified organism, the number of microbial reads found for the organism, and the Karius® designation for the pathogenicity of the organism (see Definitions).

Techniques: Diagnostic Assay, Sequencing

Patients for whom BAL fluid mcfDNA testing with the Karius® test (KT-BAL) identified Category One or Two organisms missed by standard of care (SOC) had significantly more cumulative intubation days compared to patients where KT-BAL and SOC were concordant for all Category One or Two organisms. Hospital length of stay, ICU length of stay, and ICU mortality were worse in the KT-BAL only group, but these differences were not significant (Mann-Whitney U test for continuous variables, Fisher’s exact test for mortality).

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Patients for whom BAL fluid mcfDNA testing with the Karius® test (KT-BAL) identified Category One or Two organisms missed by standard of care (SOC) had significantly more cumulative intubation days compared to patients where KT-BAL and SOC were concordant for all Category One or Two organisms. Hospital length of stay, ICU length of stay, and ICU mortality were worse in the KT-BAL only group, but these differences were not significant (Mann-Whitney U test for continuous variables, Fisher’s exact test for mortality).

Article Snippet: For each sample, the BAL fluid mcfDNA sequencing test report included the name of each identified organism, the number of microbial reads found for the organism, and the Karius® designation for the pathogenicity of the organism (see Definitions).

Techniques: MANN-WHITNEY